Article citationsMore>>

Jabbour, E., Jones, D., Kantarjian, H.M., O’Brien, S., et al. (2009) Long-Term Outcome of Patients with Chronic Myeloid Leukemia Treated with Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure Is Predicted by the in Vitro Sensitivity of BCR-ABL Kinase Domain Mutations. Blood, 114, 2037-2043.
http://dx.doi.org/10.1182/blood-2009-01-197715

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top